Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 2101 AL 2115

Trial of Cinpanemab in Early Parkinson's Disease

Lang AE, Siderowf AD, Macklin EA, Poewe W, Brooks DJ, Fernandez HH, Rascol O, Giladi N, Stocchi F, Tanner CM, Postuma RB, Simon DK, Tolosa E, Mollenhauer B, Cedarbaum JM, Fraser K, Xiao J, Evans KC, Graham DL, Sapir I, Inra J, Hutchison RM, Yang M, Fox T, Budd Haeberlein S, Dam T; SPARK Investigators.

N Engl J Med. 2022 Aug 4;387(5):408-420. doi: 10.1056/NEJMoa2203395.

Trial of Prasinezumab in Early-Stage Parkinson's Disease

Pagano G, Taylor KI, Anzures-Cabrera J, Marchesi M, Simuni T, Marek K, Postuma RB, Pavese N, Stocchi F, Azulay JP, Mollenhauer B, López-Manzanares L, Russell DS, Boyd JT, Nicholas AP, Luquin MR, Hauser RA, Gasser T, Poewe W, Ricci B, Boulay A, Vogt A, Boess FG, Dukart J, D'Urso G, Finch R, Zanigni S, Monnet A, Pross N, Hahn A, Svoboda H, Britschgi M, Lipsmeier F, Volkova-Volkmar E, Lindemann M, Dziadek S, Holiga Š, Rukina D, Kustermann T, Kerchner GA, Fontoura P, Umbricht D, Doody R, Nikolcheva T, Bonni A; PASADENA Investigators; Prasinezumab Study Group.

N Engl J Med. 2022 Aug 4;387(5):421-432. doi: 10.1056/NEJMoa2202867.

Monoclonal Antibody Therapy in Parkinson's Disease - The End?

Whone A.

N Engl J Med. 2022 Aug 4;387(5):466-467. doi: 10.1056/NEJMe2207681.

Neurotransmission Targets of Per- and Polyfluoroalkyl Substance Neurotoxicity: Mechanisms and Potential Implications for Adverse Neurological Outcomes

Brown-Leung JM, Cannon JR.

Chem Res Toxicol. 2022 Aug 15;35(8):1312-1333. doi: 10.1021/acs.chemrestox.2c00072. Epub 2022 Aug 3.

Evoked potentials generated by deep brain stimulation for Parkinson's disease

Dale J, Schmidt SL, Mitchell K, Turner DA, Grill WM.

Brain Stimul. 2022 Sep-Oct;15(5):1040-1047. doi: 10.1016/j.brs.2022.07.048. Epub 2022 Jul 31.

Pathology in the Parkinson's Progression Markers Initiative; a Finale but also a start

Camicioli R, Cookson MR.

Parkinsonism Relat Disord. 2022 Aug;101:117-118. doi: 10.1016/j.parkreldis.2022.07.015. Epub 2022 Jul 21.

The Role of Gut Microbiota in the Progression of Parkinson's Disease and the Mechanism of Intervention by Traditional Chinese Medicine

Huan P, Wang L, He Z, He J.

Neuropsychiatr Dis Treat. 2022 Jul 26;18:1507-1520. doi: 10.2147/NDT.S367016. eCollection 2022.

Efficacy of repetitive transcranial magnetic stimulation in Parkinson's disease: A systematic review and meta-analysis of randomised controlled trials

Zhang W, Deng B, Xie F, Zhou H, Guo JF, Jiang H, Sim A, Tang B, Wang Q.

EClinicalMedicine. 2022 Jul 29;52:101589. doi: 10.1016/j.eclinm.2022.101589. eCollection 2022 Oct.

Targeting Impaired Nutrient Sensing via the Glycogen Synthase Kinase-3 Pathway With Therapeutic Compounds to Prevent or Treat Dementia: A Systematic Review

Matysek A, Kimmantudawage SP, Feng L, Maier AB.

Front Aging. 2022 Jul 18;3:898853. doi: 10.3389/fragi.2022.898853. eCollection 2022.

Bidirectional Relationship Between Sleep Disturbances and Parkinson's Disease

Minakawa EN.

Front Neurol. 2022 Jul 18;13:927994. doi: 10.3389/fneur.2022.927994. eCollection 2022.

The advantage of the mini-electrode-equipped catheter for the radiofrequency ablation of paroxysmal supraventricular tachycardia

Choi Y, Kim SH, Kim H, Park JW, Ha YW, Hwang Y, Kim JH, Jang SW, Oh YS.

J Cardiovasc Electrophysiol. 2022 Oct;33(10):2164-2171. doi: 10.1111/jce.15639. Epub 2022 Aug 24.

The mini electrode-equipped catheter: Utility for paroxysmal supraventricular tachycardia ablation

Iwasawa J, Koruth JS.

J Cardiovasc Electrophysiol. 2022 Oct;33(10):2172-2173. doi: 10.1111/jce.15640. Epub 2022 Aug 24.

Viruses in neurodegenerative diseases: More than just suspects in crimes

Leblanc P, Vorberg IM.

PLoS Pathog. 2022 Aug 4;18(8):e1010670. doi: 10.1371/journal.ppat.1010670. eCollection 2022 Aug.

Mechanisms of NLRP3 activation and pathology during neurodegeneration

Jose S, Groves NJ, Roper KE, Gordon R.

Int J Biochem Cell Biol. 2022 Oct;151:106273. doi: 10.1016/j.biocel.2022.106273. Epub 2022 Aug 1.

Novel N-Linked Isoquinoline Amides as LRRK2 Inhibitors for Treating Parkinson's Disease

Sabnis RW.

ACS Med Chem Lett. 2022 Jun 21;13(7):1008-1009. doi: 10.1021/acsmedchemlett.2c00263. eCollection 2022 Jul 14.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias